Related Experiment Video
Updated: Nov 11, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
ERS International Congress 2020: highlights from the Paediatric Assembly
Cristina Ardura-Garcia1, Sara Cuevas-Ocaña2, Nadine Freitag3
1Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Insights
This review highlights key advances in pediatric respiratory medicine from the ERS Congress 2020. It covers asthma, cystic fibrosis, and early life exposures impacting lung health, emphasizing early detection and multidisciplinary care.
Area of Science:
- Pediatric Respiratory Medicine
- Pulmonology
- Allergy and Immunology
Background:
- The European Respiratory Society (ERS) Paediatric Assembly reviews significant research presented at the 2020 ERS International Congress.
- Focus areas include respiratory physiology, sleep, asthma, cystic fibrosis, infection, immunology, neonatology, and lung development.
Purpose of the Study:
- To summarize and discuss key findings in pediatric respiratory medicine from the ERS International Congress 2020.
- To highlight research on long-term respiratory outcomes, risk factors, and diagnostic challenges.
Main Methods:
- Review and discussion of selected research by Early Career Members and Chairs of the ERS Paediatric Assembly.
- Analysis of studies on lung function, disease progression, biomarkers, genetic analysis, and environmental exposures.
Main Results:
- Long-term effects of premature birth, delivery mode, and cystic fibrosis on lung function are detailed.
- Risk factors, phenotypes, and diagnostic challenges in pediatric asthma are presented.
- The utility of lung clearance index for early cystic fibrosis detection and the importance of treatable traits in bronchiectasis are confirmed.
- Impact of early-life exposures (obesity, hypoxia, pollution) on respiratory health and lung development is discussed, utilizing metabolomics and genetic analysis.
Conclusions:
- Early detection methods like the lung clearance index are valuable for conditions such as cystic fibrosis.
- Identifying treatable traits is crucial for managing bronchiectasis.
- Multidisciplinary teams are essential for treating complex pediatric airway pathologies.
- Understanding the long-term impact of early-life exposures on lung development requires advanced analytical techniques.
Abstract:
In this review, the Paediatric Assembly of the European Respiratory Society (ERS) presents a summary of the highlights and most relevant findings in the field of paediatric respiratory medicine presented at the virtual ERS International Congress 2020. Early Career Members of the ERS and Chairs of the different Groups comprising the Paediatric Assembly discuss a selection of the presented research. These cover a wide range of research areas, including respiratory physiology and sleep, asthma and allergy, cystic fibrosis, respiratory infection and immunology, neonatology and intensive care, epidemiology, bronchology and lung and airway development. Specifically, we describe the long-term effect in lung function of premature birth, mode of delivery and chronic respiratory conditions such as cystic fibrosis. In paediatric asthma, we present risk factors, phenotypes and their progression with age, and the challenges in diagnosis. We confirm the value of the lung clearance index to detect early lung changes in cystic fibrosis. For bronchiectasis treatment, we highlight the importance of identifying treatable traits. The use of biomarkers and genotypes to identify infants at risk of long-term respiratory morbidity is also discussed. We present the long-term impact on respiratory health of early life and fetal exposures to maternal obesity and intrauterine hypoxia, mechanical ventilation hyperoxia, aeroallergens, air pollution, vitamin A deficient intake and bronchitis. Moreover, we report on the use of metabolomics and genetic analysis to understand the effect of these exposures on lung growth and alveolar development. Finally, we stress the need to establish multidisciplinary teams to treat complex airway pathologies.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Metabolism
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Pharmacokinetics in Pediatric Patients: Drug Excretion
EPS and iPS Cells in Disease Research

